A multiple spacecraft detection of the 2 April 2022 M-class flare and filament eruption during the first close Solar Orbiter perihelion

CONTEXT: The Solar Orbiter mission completed its first remote-sensing observation windows in the spring of 2022. On 2 April 2022, an M-class flare followed by a filament eruption was seen both by the instruments on board the mission and from several observatories in Earth’s orbit, providing an unprecedented view of a flaring region with a large range of observations. AIMS: We aim to understand the nature of the flaring and filament eruption events via the analysis of the available dataset. The complexity of the observed features is compared with the predictions given by the standard flare model in 3D. METHOD: In this paper, we use the observations from a multi-view dataset, which includes extreme ultraviolet (EUV) imaging to spectroscopy and magnetic field measurements. These data come from the Interface Region Imaging Spectrograph, the Solar Dynamics Observatory, Hinode, as well as several instruments on Solar Orbiter. RESULTS: The large temporal coverage of the region allows us to analyse the whole sequence of the filament eruption starting with its pre-eruptive state. Information given by spectropolarimetry from SDO/HMI and Solar Orbiter PHI/HRT shows that a parasitic polarity emerging underneath the filament is responsible for bringing the flux rope to an unstable state. As the flux rope erupts, Hinode EIS captures blue-shifted emission in the transition region and coronal lines in the northern leg of the flux rope prior to the flare peak. This may be revealing the unwinding of one of the flux rope legs. At the same time, Solar Orbiter SPICE captures the whole region, complementing the Doppler diagnostics of the filament eruption. Analyses of the formation and evolution of a complex set of flare ribbons and loops, of the hard and soft X-ray emissions with STIX, show that the parasitic emerging bipole plays an important role in the evolution of the flaring region. CONCLUSIONS: The extensive dataset covering this M-class flare event demonstrates how important multiple viewpoints and varied observations are in order to understand the complexity of flaring regions. While the analysed data are overall consistent with the standard flare model, the present particular magnetic configuration shows that surrounding magnetic activity such as nearby emergence needs to be taken into account to fully understand the processes at work. This filament eruption is the first to be covered from different angles by spectroscopic instruments, and provides an unprecedented diagnostic of the multi-thermal structures present before and during the flare. This complete dataset of an eruptive event showcases the capabilities of coordinated observations with the Solar Orbiter mission

Spatial distribution of micrometre‐scale porosity and permeability across the damage zone of a reverse‐reactivated normal fault in a tight sandstone : Insights from the Otway Basin, SE Australia

This research forms part of a PhD project supported by the Australian Research Council [Discovery Project DP160101158] and through an Australian Government Research Training Program Scholarship. Dave Healy acknowledges the support of the Natural Environment Research Council (NERC, UK) through the award NE/N003063/1 ‘Quantifying the Anisotropy of Permeability in Stressed Rock’. This study was also funded by scholarships from the Petroleum Exploration Society of Australia and the Australian Petroleum Production and Exploration Association. We thank Gordon Holm for preparing thin sections and Colin Taylor for carrying out particle size measurements and mercury injection capillary pressure analyses. Aoife McFadden and David Kelsey from Adelaide Microscopy, Braden Morgan, and Sophie Harland are acknowledged for their assistance with laboratory work. Field assistants James Hall, Rowan Hansberry, and Lachlan Furness are also gratefully acknowledged for their assistance with sample collection. Discussions with Ian Duddy on the mineralogy of the Eumeralla Formation are also greatly appreciated. This forms TRaX record 416.Peer reviewedPublisher PD

Modelling credit spreads with time volatility, skewness, and kurtosis

This paper seeks to identify the macroeconomic and financial factors that drive credit spreads on bond indices in the US credit market. To overcome the idiosyncratic nature of credit spread data reflected in time varying volatility, skewness and thick tails, it proposes asymmetric GARCH models with alternative probability density functions. The results show that credit spread changes are mainly explained by the interest rate and interest rate volatility, the slope of the yield curve, stock market returns and volatility, the state of liquidity in the corporate bond market and, a heretofore overlooked variable, the foreign exchange rate. They also confirm that the asymmetric GARCH models and Student-t distributions are systematically superior to the conventional GARCH model and the normal distribution in in-sample and out-of-sample testing

EnGraft: a multicentre, open-label, randomised, two-arm, superiority study protocol to assess bioavailability and practicability of Envarsus® versus Advagraf™ in liver transplant recipients

Background Graft rejection and chronic CNI toxicity remain obstacles to organ transplant success. Current formulations of tacrolimus, such as Prograf® and Advagraf™, exhibit limitations in terms of pharmacokinetics and tolerability, related in part to suboptimal bioavailability. As dosing non-compliance can result in graft rejection, the once daily formulation of tacrolimus, Advagraf™, was developed (vs 2x/day Prograf®). Benefits of Advagraf™ are counterbalanced by delayed achievement of therapeutic trough levels and need for up to 50% higher doses to maintain Prograf®-equivalent troughs. Envarsus® is also a prolonged-release once-daily tacrolimus formulation, developed using MeltDose™ drug-delivery technology to increase drug bioavailability; improved bioavailability results in low patient drug absorption variability and less pronounced peak-to-trough fluctuations. In phase III de novo kidney transplant studies, Envarsus® proved non-inferior to twice-daily tacrolimus; however, no phase IV studies show superiority of Envarsus® vs Advagraf™ in de novo liver transplant (LTx) recipients. Methods The EnGraft compares bioavailability and tests superiority of Envarsus® (test arm) versus Advagraf™ (comparator arm) in de novo LTx recipients. A total of 268 patients from 15 German transplant centres will be randomised 1:1 within 14 days post-LTx. The primary endpoint is dose-normalised trough level (C/D ratio) measured 12 weeks after randomisation. Secondary endpoints include the number of dose adjustments, time to reach first defined trough level and incidence of graft rejections. Additionally, clinical and laboratory parameters will be assessed over a 3-year period. Discussion C/D ratio is an estimate for tacrolimus bioavailability. Improving bioavailability and increasing C/D ratio using Envarsus could reduce renal dysfunction and other tacrolimus-related toxicities; previous trials have shown that a higher C/D ratio (i.e. slower tacrolimus metabolism) is not only associated with improved renal function but also linked to reduced neurotoxic side effects. A higher C/D ratio could improve clinical outcomes for LTx recipients; EnGraft has begun, with one third of patients recruited by January 2022

Impact of opioid-free analgesia on pain severity and patient satisfaction after discharge from surgery: multispecialty, prospective cohort study in 25 countries

Background: Balancing opioid stewardship and the need for adequate analgesia following discharge after surgery is challenging. This study aimed to compare the outcomes for patients discharged with opioid versus opioid-free analgesia after common surgical procedures.Methods: This international, multicentre, prospective cohort study collected data from patients undergoing common acute and elective general surgical, urological, gynaecological, and orthopaedic procedures. The primary outcomes were patient-reported time in severe pain measured on a numerical analogue scale from 0 to 100% and patient-reported satisfaction with pain relief during the first week following discharge. Data were collected by in-hospital chart review and patient telephone interview 1 week after discharge.Results: The study recruited 4273 patients from 144 centres in 25 countries; 1311 patients (30.7%) were prescribed opioid analgesia at discharge. Patients reported being in severe pain for 10 (i.q.r. 1-30)% of the first week after discharge and rated satisfaction with analgesia as 90 (i.q.r. 80-100) of 100. After adjustment for confounders, opioid analgesia on discharge was independently associated with increased pain severity (risk ratio 1.52, 95% c.i. 1.31 to 1.76; P < 0.001) and re-presentation to healthcare providers owing to side-effects of medication (OR 2.38, 95% c.i. 1.36 to 4.17; P = 0.004), but not with satisfaction with analgesia (beta coefficient 0.92, 95% c.i. -1.52 to 3.36; P = 0.468) compared with opioid-free analgesia. Although opioid prescribing varied greatly between high-income and low- and middle-income countries, patient-reported outcomes did not.Conclusion: Opioid analgesia prescription on surgical discharge is associated with a higher risk of re-presentation owing to side-effects of medication and increased patient-reported pain, but not with changes in patient-reported satisfaction. Opioid-free discharge analgesia should be adopted routinely

Fate of selected estrogenic hormones in an urban sewage treatment plant in Tunisia (North Africa)

© 2014 Elsevier B.V. Estrogenic compounds have been monitored for one year at an urban sewage treatment plant (STP) located in Tunisia, to evaluate their fate and seasonal variations. The concentrations of these compounds were determined in both wastewater and sludge phases by gas chromatography coupled with mass spectrometry (GC-MS). Results showed that the highest removal of all estrogens (≥. 80%) was observed in summer. Mass balance analysis revealed that biodegradation was the predominant removal mechanism. Moreover, the results showed that the removal efficiency of the studied emerging micropollutants and their concentrations in the solid phase of return sludge were much higher in winter and spring than in summer and autumn. These findings were closely related to microbial activity and the concentration of mixed liquor suspended solids (MLSSs). Finally, the findings can be used to help with the modifications that could be implemented in that STP for the improved removal of estrogenic contaminants

Polycyclic aromatic hydrocarbon degradation and biosurfactant production by a newly isolated Pseudomonas sp. strain from used motor oil-contaminated soil

The aim of this study was to isolate and characterize a newly isolated bacterium, designated strain W10, a polycyclic aromatic hydrocarbon (PAHs) degrader and biosurfactant producer, belonged to Pseudomonas genus and closely related to Pseudomonas aeruginosa, with the 16 rRNA gene sequence similarity of 99.1%. Based on GC-MS analyses, it degraded around 80% of phenanthrene, used as the sole carbon and energy source, at an initial concentration of 200 mg l−1, after 30 days of incubation at 37 °C and 180 rpm, reducing the surface tension (ST) from 56.1 to 42 mN m−1 after 4 days of incubation. Furthermore, strain W10 utilized about 10%, 20%, 90%, and 99% of hexadecane (C16), pyrene, fluoranthene, and crude oil, respectively, after 30 days of incubation at 37 °C and 180 rpm. During the growth of strain W10 on phenanthrene and fluoranthene, some metabolites were identified, supporting the biodegradation pathways of the two PAHs. Interestingly, strain W10 showed also a significant potential to produce surface-active agents reducing the surface tension to 32 mN m−1 and reaching a production around 2 g l−1 after 48 h of incubation, in the presence of olive oil (1%,v/v) as substrate, at 37 °C and 180 rpm. Its biosurfactant, namely BSW10, showed an interesting emulsification activity and a high stability over a wide range of salinity (0–150 g l−1), temperature (0–100 °C), pH (2–12) and thus a promising abilities in used motor oil and crude oil removal from contaminated soils. Overall, these results provide evidence that strain W10 and its biosurfactant (BSW10) could be potential candidates for further bioremediation applications